Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 8c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q3 EPS of ($0.70), $0.08 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• Best Buy (BBY) Tops Q2 EPS by 12c, Offers Guidance
• Enbridge forms C$2.7B joint venture with KKR and Apollo
• Burlington Stores (BURL) Tops Q2 EPS by 20c, Misses on Revenue